Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference183 articles.
1. Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea;Abigerges;Journal of the National Cancer Institute,1994
2. Potential repurposing of known drugs as potent bacterial β-glucuronidase inhibitors;Ahmad;Journal of Biomolecular Screening,2012
3. Gut microbiota modulation of chemotherapy efficacy and toxicity;Alexander;Nature Reviews. Gastroenterology & Hepatology,2017
4. New approaches to prevent intestinal toxicity of irinotecan-based regimens;Alimonti;Cancer Treatment Reviews,2004
5. Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11;Araki;Japanese Journal of Cancer Research: Gann,1993
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigation of the inhibitory activity of triterpenoids isolated from Actinidia polygama stems against β-glucuronidase via enzyme kinetics, molecular docking, and molecular dynamics analyses;Journal of Molecular Structure;2024-12
2. Camptothecin multifunctional nanoparticles effectively achieve a balance between the efficacy of breast cancer treatment and the preservation of intestinal homeostasis;Bioactive Materials;2024-11
3. Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities;Gut Microbes;2024-08-16
4. Is There an Interplay between Environmental Factors, Microbiota Imbalance, and Cancer Chemotherapy-Associated Intestinal Mucositis?;Pharmaceuticals;2024-08-03
5. Modulating the gut microbiome in non-small cell lung cancer: Challenges and opportunities;Lung Cancer;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3